February 24, 2026

Structure Therapeutics Inc. (GPCR): Analyst Consensus Points to a 60% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) has captured the attention of investors in the biotechnology sector, primarily due to its innovative approach to addressing chronic diseases with unmet medical needs. The..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 17.73% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) is emerging as an intriguing opportunity for investors within the healthcare sector, particularly those focused on medical care facilities. With a market capitalization of..

Biohaven Ltd. (BHVN) Stock Analysis: Navigating a Potential 80% Upside in the Biotechnology Sector

Biohaven Ltd. (NYSE: BHVN) stands as a compelling figure in the biotechnology landscape with a staggering 80.81% potential upside, according to the latest analyst ratings. Specializing in developing therapies for..

Arrowhead Pharmaceuticals, Inc. (ARWR): An Investor Outlook on Its 28.86% Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is capturing investor attention with its substantial growth potential. With a market capitalization of $8.84 billion and a..

Disc Medicine, Inc. (IRON) Stock Analysis: A High-Risk, High-Reward Play with 61.59% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector, capturing the attention of investors with its impressive market cap of $2.42 billion and a potential upside of..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 36% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands as a noteworthy contender in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.86 billion, this Massachusetts-based company..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Strong Buy Ratings Signal a 57% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a portfolio targeting some of the most challenging neurodegenerative and lysosomal storage diseases. Based in South San Francisco,..

Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with a significant potential upside of 37.95%. Headquartered in..

Evotec SE (EVO) Investor Outlook: Exploring a 66% Upside Potential in the Drug Discovery Sector

Evotec SE (EVO), a German-based leader in drug discovery and development, is capturing the attention of investors with its potential upside of 66.21% based on current analyst price targets. As..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 206.86% Potential Upside in the Healthcare Sector

Evolent Health, Inc. (NYSE: EVH) stands at a crossroads of opportunity and challenge, making it a compelling consideration for investors focused on the healthcare sector. With its current market cap..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a Promising 47% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP), a prominent player in the healthcare sector, operates within the highly competitive drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. With a market capitalization..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: 49.84% Potential Upside in the Biotech Frontier

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is capturing the attention of investors with its impressive potential upside, as the company embarks on a groundbreaking journey in the biotechnology sector. With a..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 78.68% Potential Upside in Biotechnology

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, has captured the attention of investors with a notable market cap of $2.99 billion and a promising pipeline..

National HealthCare Corporation (NHC): A Look at Performance Highlights and Market Position in the Healthcare Sector

As an investor, keeping an eye on National HealthCare Corporation (NYSE: NHC) could be a strategic move, especially given its robust presence in the healthcare sector. Based in Murfreesboro, Tennessee,..

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 43.58% Upside Potential

Haemonetics Corporation (NYSE: HAE) is capturing investor attention with its promising potential for a substantial upside. Positioned within the healthcare sector, this Boston-based medical device company specializes in an array..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 27% Upside Potential and Robust CNS Portfolio

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector with a focus on central nervous system (CNS) disorders and rare diseases. With a current market capitalization of $4.18..

The Pennant Group, Inc. (PNTG): Investor Outlook on a Healthcare Growth Opportunity with a 15% Upside

As investors navigate the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents an intriguing opportunity. Headquartered in Eagle, Idaho, this company operates in the medical care facilities industry, providing..

Phreesia, Inc. (PHR) Stock Analysis: A Healthcare SaaS Innovator with a Promising 139.77% Potential Upside

Investors seeking exposure to the dynamic intersection of technology and healthcare might find Phreesia, Inc. (PHR) an intriguing prospect. This Delaware-based company offers a comprehensive SaaS-based platform that revolutionizes patient..

Kestra Medical Technologies, Ltd. (KMTS) Investor Outlook: Exploring a Promising 8.65% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering company in the healthcare sector, is capturing investor attention with its innovative wearable medical devices and digital healthcare solutions. Based in Kirkland, Washington,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and 7.12% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention as a promising player in the biotechnology sector, offering innovative treatments for serious diseases. Despite a challenging financial landscape, the..

Search

Funds

February 24, 2026

Search

Funds

February 24, 2026

FTSE 100

Funds